User:As in liberty/Tobacco Products Scientific Advisory Committee

Source: Wikipedia, the free encyclopedia.

The Tobacco Products Scientific Advisory Committee (TPSAC) is an advisory panel of the

tobacco products.[1][2] It was created in accordance to the Family Smoking Prevention and Tobacco Control Act, signed into law by President Barack Obama on June 22, 2009.[3]

Structure and mission

TPSAC consists of 12 members, including a chairperson, all of whom are selected by the FDA commissioner from among experts in medicine, medical ethics, science and technology related to the manufacture and use of tobacco products. Nine voting seats are held for academics and practitioners in the field of health care, while three non-voting seats are held for industry representatives. Members serve for overlapping terms of four years.

menthol in cigarettes on the public health, and advising on "modified risk" (i.e. "light") tobacco products.[1]

Membership

Voting members

  • Jonathan M. Samet, M.D., M.S., chair
  • Neal L. Benowitz, M.D.
  • Mark Stuart Clanton, M.D., M.P.H.
  • Gregory Niles Connolly, D.M.D., M.P.H.
  • Karen L. DeLeeuw, M.S.W.
  • Patricia Nez Henderson, M.P.H., M.D.
  • Jack E. Henningfield, Ph.D.
  • Melanie Wakefield, Ph.D.

Non-voting members

  • Luby Arnold Hamm, Jr.
  • Jonathan Daniel Heck, Ph.D., DABT
  • John H. Lauterbach, Ph.D., DABT

Controversy

On March 1, 2010, the Wall Street Journal reported that proposed committee members Jack Henningfield and Neal L. Benowitz, had served as consultants to

Boston Globe.[5] Meanwhile, advocacy group Americans for Limited Government has raised concerns about funding received by TPSAC chair Jonathan Samet from GlaxoSmithKline and other pharmaceutical companies.[6]

References

External links

[[Category:Food and Drug Administration]] [[Category:Tobacco in the United States]] [[Category:Tobacco control]]